ASTH vs RMR

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 02, 2026

ASTH

58.5
AI Score
VS
ASTH Wins

RMR

32.8
AI Score

Investment Advisor Scores

ASTH

59score
Recommendation
HOLD

RMR

33score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric ASTH RMR Winner
Forward P/E 8.9686 14.6628 ASTH
PEG Ratio 0 0.0873 Tie
Revenue Growth 48.5% 8.4% ASTH
Earnings Growth 110.5% -26.6% ASTH
Tradestie Score 58.5/100 32.8/100 ASTH
Profit Margin 1.1% 8.9% RMR
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY ASTH

Relative Price Performance (Last 90 Days)

ASTH 1M: -9.6% · 3M: -29.0% RMR 1M: -6.0% · 3M: -11.9%

Current Technical Phase

ASTH

Markdown
Sell / avoid

Price below a falling SMA50 (slope -9.4%), weak momentum, RSI 43

RSI (14): 42.7 · Price: $34.91

RMR

Markdown
Sell / avoid

Price below a falling SMA50 (slope -3.1%), weak momentum, RSI 30

RSI (14): 29.7 · Price: $18.06

Fundamentals Snapshot

Metric ASTH RMR
Market Cap — —
Forward P/E 9.6 24.7
Trailing P/E 43.4 15.7
Revenue (TTM) — —
Revenue Growth 0.5% 0.1%
Gross Margin 0.1% 1.0%
Operating Margin 0.0% 0.2%
EPS 0.82 1.15
Dividend Yield — 0.10%

Frequently Asked Questions

Based on our detailed analysis, ASTH is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.